Yongjie Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yongjie Ma has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chunting Wu
Department of Nutrition, School of Public Health, Dali University, Dali, Yunnan, China
1 shared publication - Fuli Ya
Department of Nutrition, School of Public Health, Dali University, Dali, Yunnan Province 671000, China
1 shared publication - Qilian He
School of Nursing, Dali University, Dali, 671000, China.
1 shared publication - Weiqi Li
Department of Nutrition, School of Public Health, Dali University, Dali, Yunnan, China
1 shared publication - Xinhui Huang
Department of Nutrition, School of Public Health, Dali University, Dali, Yunnan, China
1 shared publication - Xinyu Zhou
Department of Nutrition, School of Public Health, Dali University, Dali, Yunnan, China
1 shared publication
Latest Publications
- Open Access
- 23 February 2023
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 21 (1) , 189-197
Sulforaphane attenuates platelet granule secretion through down-regulating glycoprotein VI-mediated p38 MAPK/cPLA 2 signaling pathway
Glycoprotein VI (GPVI) is the major collagen receptor on the platelet surface and is important in mediating granule secretion and atherothrombosis. Sulforaphane (SFN), a dietary isothiocyanate enriched in cruciferous vegetables, exerts multiple biological activities. This study aimed to investigate the efficacy of SFN on GPVI-mediated signaling and platelet granule secretion in vitro. We herein demonstrated that SFN greatly attenuated granule secretion in human gel-filtered platelets in response to collagen, including inhibiting CD62P and CD63 expression and PF4, CCL5, and ATP release. Mechanistically, these inhibitory effects of SFN were mainly mediated by its attenuation of cytosolic phospholipase A2 (cPLA2) phosphorylation and thromboxane A2 (TxA2) generation. Moreover, SFN did not further decrease the inhibitory effects of p38 MAPK inhibitor SB203580 on cPLA2 phosphorylation, TxA2 generation and granule secretion. Thus, SFN attenuates platelet granule secretion via down-regulating GPVI-mediated p38 MAPK/cPLA2/TxA2 signaling, which may play important preventive roles in cardiovascular diseases.
- 23 February 2023
- Published by Taylor & Francis in CyTA - Journal of Food
- Vol. 21 (1) , 189-197
Open AccessSulforaphane attenuates platelet granule secretion through down-regulating glycoprotein VI-mediated p38 MAPK/cPLA 2 signaling pathway
Glycoprotein VI (GPVI) is the major collagen receptor on the platelet surface and is important in mediating granule secretion and atherothrombosis. Sulforaphane (SFN), a dietary isothiocyanate enriched in cruciferous vegetables, exerts multiple biological activities. This study aimed to investigate the efficacy of SFN on GPVI-mediated signaling and platelet granule secretion in vitro. We herein demonstrated that SFN greatly attenuated granule secretion in human gel-filtered platelets in response to collagen, including inhibiting CD62P and CD63 expression and PF4, CCL5, and ATP release. Mechanistically, these inhibitory effects of SFN were mainly mediated by its attenuation of cytosolic phospholipase A2 (cPLA2) phosphorylation and thromboxane A2 (TxA2) generation. Moreover, SFN did not further decrease the inhibitory effects of p38 MAPK inhibitor SB203580 on cPLA2 phosphorylation, TxA2 generation and granule secretion. Thus, SFN attenuates platelet granule secretion via down-regulating GPVI-mediated p38 MAPK/cPLA2/TxA2 signaling, which may play important preventive roles in cardiovascular diseases.